AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Accrued Liabilities of -$3.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-05
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$5.44M, a 133.99% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $2.04M, a 26.56% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $13.93M, a 185.70% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $15.82M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $48.53M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$12.78M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$10.02M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$38.01M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$3.41M 10-Q · filed 2026-08-05 | $10.52M derived: sum of 3 quarters · filed 2026-08-05 | $26.35M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $2.04M 10-Q · filed 2026-05-07 | $15.96M derived: sum of 2 quarters · filed 2026-05-07 | $31.79M derived: sum of 3 quarters · filed 2026-05-07 | $47.79M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $13.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $29.75M derived: sum of 2 quarters · filed 2026-02-26 | $45.76M derived: sum of 3 quarters · filed 2026-08-05 | $48.53M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $15.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $31.83M derived: sum of 2 quarters · filed 2026-08-05 | $34.60M 10-Q · filed 2025-11-10 | $39.48M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $16.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $18.78M 10-Q · filed 2026-08-05 | $23.65M derived: sum of 3 quarters · filed 2026-08-05 | $20.53M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $2.77M 10-Q · filed 2026-05-07 | $7.65M derived: sum of 2 quarters · filed 2026-05-07 | $4.52M derived: sum of 3 quarters · filed 2026-05-07 | $5.04M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.75M derived: sum of 2 quarters · filed 2026-02-26 | $2.27M derived: sum of 3 quarters · filed 2026-02-26 | -$12.78M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.61M derived: sum of 2 quarters · filed 2025-11-10 | -$17.65M 10-Q · filed 2025-11-10 | -$13.94M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $519.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$14.53M 10-Q · filed 2025-08-07 | -$10.81M derived: sum of 3 quarters · filed 2026-02-26 | -$5.17M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$15.04M 10-Q · filed 2025-05-08 | -$11.33M derived: sum of 2 quarters · filed 2026-02-26 | -$5.68M derived: sum of 3 quarters · filed 2026-02-26 | $49.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.36M derived: sum of 2 quarters · filed 2026-02-26 | $15.09M derived: sum of 3 quarters · filed 2026-02-26 | -$10.02M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $5.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $11.38M derived: sum of 2 quarters · filed 2024-11-07 | -$13.73M 10-Q · filed 2024-11-07 | -$30.21M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $5.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$19.38M 10-Q · filed 2024-08-08 | -$35.85M derived: sum of 3 quarters · filed 2024-08-08 | -$37.92M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$25.11M 10-Q · filed 2024-05-09 | -$25.05M 10-Q · filed 2023-05-08 | -$41.59M derived: sum of 2 quarters · filed 2024-05-09 | -$43.66M derived: sum of 3 quarters · filed 2024-05-09 | -$70.51M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$16.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$18.54M derived: sum of 2 quarters · filed 2024-03-14 | -$45.39M derived: sum of 3 quarters · filed 2024-03-14 | -$38.01M 10-K · filed 2024-03-14 | -$38.23M 10-K · filed 2023-03-10 | |||
| 2022-09-30 | -$2.07M derived: 10-Q 9 month − 10-K/A 6 month · filed 2023-11-08 | -$28.92M derived: sum of 2 quarters · filed 2023-11-08 | -$21.53M 10-Q · filed 2023-11-08 | -$22.36M 10-Q · filed 2022-11-03 | -$58.71M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$26.85M derived: 10-K/A 6 month − 10-K/A 3 month · filed 2023-08-28 | -$19.46M 10-K/A · filed 2023-08-28 | -$18.63M 10-Q · filed 2022-08-04 | -$56.64M derived: sum of 3 quarters · filed 2023-08-28 | -$25.84M derived: sum of 4 quarters · filed 2023-08-28 | |||
| 2022-03-31 | $7.39M 10-K/A · filed 2023-08-28 | $4.43M 10-Q · filed 2022-05-09 | -$29.79M derived: sum of 2 quarters · filed 2023-08-28 | $1.01M derived: sum of 3 quarters · filed 2023-08-28 | -$9.82M derived: sum of 4 quarters · filed 2023-08-28 | |||
| 2021-12-31 | -$37.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | -$6.37M derived: sum of 2 quarters · filed 2023-08-28 | -$17.20M derived: sum of 3 quarters · filed 2023-08-28 | -$22.08M 10-K/A · filed 2023-08-28 | -$24.68M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $30.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $19.98M derived: sum of 2 quarters · filed 2022-11-03 | $15.10M 10-Q · filed 2022-11-03 | $27.43M derived: sum of 4 quarters · filed 2023-08-28 | ||||
| 2021-06-30 | -$10.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$15.71M 10-Q · filed 2022-08-04 | -$3.38M derived: sum of 3 quarters · filed 2023-08-28 | -$23.06M derived: sum of 4 quarters · filed 2023-08-28 | ||||
| 2021-03-31 | -$4.88M 10-Q · filed 2022-05-09 | $7.45M derived: sum of 2 quarters · filed 2023-08-28 | -$12.23M derived: sum of 3 quarters · filed 2023-08-28 | $5.59M derived: sum of 4 quarters · filed 2023-08-28 | ||||
| 2020-12-31 | $12.33M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | -$7.35M derived: sum of 2 quarters · filed 2023-08-28 | $10.47M derived: sum of 3 quarters · filed 2023-08-28 | $6.26M 10-K/A · filed 2023-08-28 | $6.36M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | -$19.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$1.86M derived: sum of 2 quarters · filed 2021-11-04 | -$6.07M 10-Q · filed 2021-11-04 | -$4.25M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $17.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $13.61M 10-Q · filed 2021-08-05 | $15.44M derived: sum of 3 quarters · filed 2022-03-01 | $14.39M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$4.21M 10-Q · filed 2021-05-10 | -$2.38M derived: sum of 2 quarters · filed 2022-03-01 | -$3.43M derived: sum of 3 quarters · filed 2022-03-01 | -$14.06M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $775.00K derived: sum of 2 quarters · filed 2022-03-01 | -$9.85M derived: sum of 3 quarters · filed 2022-03-01 | -$27.35M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$11.68M derived: sum of 2 quarters · filed 2020-11-05 | -$29.18M 10-Q · filed 2020-11-05 | -$15.81M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$10.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$28.13M 10-Q · filed 2020-08-10 | -$14.76M derived: sum of 3 quarters · filed 2021-02-25 | -$1.19M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$17.50M 10-Q · filed 2020-05-05 | -$4.14M derived: sum of 2 quarters · filed 2021-02-25 | $9.44M derived: sum of 3 quarters · filed 2021-02-25 | $35.58M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $13.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $26.93M derived: sum of 2 quarters · filed 2021-02-25 | $53.08M derived: sum of 3 quarters · filed 2021-02-25 | $55.48M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $13.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $39.72M derived: sum of 2 quarters · filed 2019-11-12 | $42.12M 10-Q · filed 2019-11-12 | $72.93M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $26.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $28.55M 10-Q · filed 2019-08-08 | $59.35M derived: sum of 3 quarters · filed 2020-03-12 | $52.07M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $2.40M 10-Q · filed 2019-05-09 | $33.21M derived: sum of 2 quarters · filed 2020-03-12 | $25.92M derived: sum of 3 quarters · filed 2020-03-12 | $20.38M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $30.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $23.52M derived: sum of 2 quarters · filed 2020-03-12 | $17.98M derived: sum of 3 quarters · filed 2020-03-12 | $21.97M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$7.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$12.83M derived: sum of 2 quarters · filed 2018-11-08 | -$8.83M 10-Q · filed 2018-11-08 | $3.85M derived: sum of 4 quarters · filed 2019-03-26 | ||||
| 2017-06-30 | -$5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$1.55M 10-Q · filed 2018-08-08 | $11.14M derived: sum of 3 quarters · filed 2019-03-26 | $12.79M derived: sum of 4 quarters · filed 2019-03-26 | ||||
| 2017-03-31 | $4.00M 10-Q · filed 2018-05-09 | $16.68M derived: sum of 2 quarters · filed 2019-03-26 | $18.34M derived: sum of 3 quarters · filed 2019-03-26 | $23.24M derived: sum of 4 quarters · filed 2019-03-26 | ||||
| 2016-12-31 | $12.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $14.34M derived: sum of 2 quarters · filed 2019-03-26 | $19.25M derived: sum of 3 quarters · filed 2019-03-26 | $20.70M 10-K · filed 2019-03-26 | ||||
| 2016-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $6.56M derived: sum of 2 quarters · filed 2017-11-08 | $8.02M 10-Q · filed 2017-11-08 | $8.64M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $4.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $6.36M 10-Q · filed 2017-08-08 | $6.98M derived: sum of 3 quarters · filed 2018-03-12 | $12.39M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $1.46M 10-Q · filed 2017-05-09 | $2.08M derived: sum of 2 quarters · filed 2018-03-12 | $7.48M derived: sum of 3 quarters · filed 2018-03-12 | $6.51M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | $622.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $6.02M derived: sum of 2 quarters · filed 2018-03-12 | $5.06M derived: sum of 3 quarters · filed 2018-03-12 | $4.65M 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | $5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.43M derived: sum of 2 quarters · filed 2016-11-09 | $4.02M 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | -$967.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$1.38M 10-Q · filed 2016-08-08 | ||||||
| 2015-03-31 | -$411.00K 10-Q · filed 2016-05-05 | |||||||
| 2014-12-31 | $2.75M 10-K · filed 2017-03-06 | |||||||
| 2013-12-31 | $1.98M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |